ARV production is an Indian government responsibility

Human Rights Watch recently invited Lives in Focus to collaborate on a Web log in conjunction with the XVI International AIDS Conference in Toronto, Canada from Aug. 13-18.

One of the speakers, Anand Grover, the co-founder of the Mumbai Lawyers Collective HIV/AIDS Unit, delivered a speech on the second day of the conference titled “Human rights and Social Vulnerabilities,” in which he expressed concern about the availability of inexpensive generic drugs in five to ten years with India’s agreement to comply with the Agreement on Trade -Related Aspects of Intellectual Property Rights (TRIPS) regarding product patents.

Lives in Focus had interviewed Grover in Mumbai earlier about this subject and asked what alternatives there are to Western pharmaceutical companies imposing licenses on Indian generic drug makers and why the Indian government itself does not begin production of the drugs. Listen to his thoughts on the subject in this audio clip.


Related Previous Posting:

Anand Grover addresses the gulf between the Indian government’s statistics and NGOs statistics on the number of people infected with the HIV virus. (Audio Interview).

Anand Grover discusses condoms and Morality (Video Interview).

Comments are closed.